Overview

Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum TWEAK Level in Psoriasis

Status:
Active, not recruiting
Trial end date:
2021-12-15
Target enrollment:
0
Participant gender:
All
Summary
The aim of the study is to evaluate the effect of NB-UVB versus MTX on serum TWEAK level in psoriatic patients.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Aswan University Hospital
Treatments:
Methotrexate
Criteria
Inclusion Criteria:

- Patients with moderate to severe plaque psoriasis of any age and gender.

Exclusion Criteria:

- History of psoriasis treatment with systemic and biological agents prior to the study
for at least 3 months.

- Pregnancy and lactation.

- Infections

- Patients with chronic diseases: hepatic disorders, hematologic disease, chronic renal
failure or cancer